Reaction

Fungaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,544 reports · 111 co-occurring drugs

As of the last recalculation, Fungaemia appears in 1,544 FAERS reports alongside 111 co-occurring drug terms. The strongest observed disproportionality signal is MICAFUNGIN SODIUM (PRR 137.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Micafungin Sodium	82	137.6	139.0
Amphotericin B	101	116.2	117.1
Posaconazole Delayed-Release	54	68.7	69.0
Voriconazole Injection	99	65.6	65.9
Meropenem	131	60.0	60.3
Cefepime	55	53.6	53.8
Posaconazole	61	52.6	52.8
Voriconazole	110	52.5	52.7
Cefepime Hydrochloride	59	51.3	51.5
Cytarabine	178	45.0	45.1
Ampicillin	26	43.0	43.2
Ampicillin Sodium	26	43.0	43.2
Vancomycin	157	40.7	40.8
Vancomycin Hydrochloride	171	39.2	39.3
Piperacillin And Tazobactam	36	38.8	38.9
Piperacillin Sodium,Tazobactam Sodium	71	37.8	37.9
Basiliximab	31	36.2	36.3
Fludarabine Phosphate	97	35.4	35.5
Piperacillin Sodium And Tazobactam Sodium	48	34.0	34.1
Pegaspargase	30	33.7	33.7
Amikacin	39	31.6	31.7
Cefazolin	21	31.4	31.5
Terbinafine Hydrochloride	20	30.7	30.8
Fluconazole	145	30.7	30.7
Ganciclovir Sodium	23	29.7	29.8
Remdesivir	28	28.8	28.9
Ganciclovir	20	26.7	26.7
Busulfan	30	26.2	26.2
Gentamicin Sulfate	29	25.2	25.2
Cefazolin Sodium	22	24.9	25.0
Blinatumomab	19	24.8	24.9
Ceftriaxone	58	24.7	24.8
Gentamicin	23	24.0	24.1
Daptomycin	16	23.6	23.7
Alemtuzumab	33	23.5	23.5
Thiotepa	16	22.8	22.8
Ceftriaxone Sodium	60	21.9	21.9
Norepinephrine Bitartrate	23	21.8	21.9
Melphalan	36	21.8	21.9
Hydrocortisone Sodium Succinate	15	21.7	21.7
Melphalan Hydrochloride	39	21.5	21.5
Etoposide	100	19.5	19.6
Axicabtagene Ciloleucel	14	19.3	19.3
Minocycline	16	18.7	18.7
Mesna Injection	11	18.1	18.1
Chlorhexidine Gluconate	12	17.8	17.9
Norepinephrine	13	16.5	16.5
Mesna	10	16.1	16.1
Vincristine Sulfate	33	15.5	15.5
Azacitidine For	20	15.0	15.0
Magnesium Sulfate In Water For	14	14.9	14.9
Levofloxacin	63	14.6	14.7
Levofloxacin In 5% Dextrose	63	14.6	14.7
Magnesium Sulfate Heptahydrate	14	14.6	14.6
Magnesium Sulfate	14	14.6	14.6
Cyclophosphamide Injection, Solution	165	13.9	14.0
Cyclophosphamide	165	13.9	14.0
Cyclophosphamide For Injection	165	13.9	14.0
Imatinib	18	13.9	13.9
Mycophenolate Mofetil	126	13.5	13.5
Methylprednisolone	128	13.5	13.5
Mycophenolate Mofetil Hydrochloride	126	13.5	13.5
Valganciclovir Hydrochloride Powder,	12	13.4	13.4
Dextrose Monohydrate	13	13.2	13.2
Tacrolimus	136	12.7	12.7
Dextrose	12	12.4	12.4
Tacrolimus Ointment 0.1%	105	12.1	12.1
Ciprofolxacin	62	12.1	12.1
Ciprofloxacin Tablets	62	12.1	12.1
Teduglutide	12	12.1	12.1
Tacrolimus Extended-Release Capsules	105	12.1	12.1
Atovaquone	7	11.8	11.8
Anti-Thymocyte Globulin (Rabbit)	7	11.7	11.8
Filgrastim	32	11.7	11.7
Itraconazole	10	11.6	11.6
Valganciclovir	16	11.5	11.6
Valganciclovir Hydrochloride	16	11.5	11.6
Pyrazinamide	8	11.5	11.5
Azacitidine	25	11.5	11.5
Linezolid	25	11.5	11.5
Anakinra	14	11.5	11.5
Calcium Gluconate	10	11.3	11.3
Mycophenilic Acid	17	11.2	11.2
Sirolimus	11	11.1	11.1
Ciprofloxacin	72	11.0	11.1
Ifosfamide	17	10.8	10.8
Bendamustine Hcl	12	10.5	10.5
Metronidazole Topical	36	10.4	10.4
Dexamethasone Sodium Phosphate	7	9.3	9.3
Bleomycin Sulfate	7	9.2	9.2
Doxorubicin	58	9.1	9.1
Heparin Sodium	9	8.9	8.9
Cladribine	6	8.4	8.4
Baricitinib	6	8.4	8.4
Isoniazid	10	8.4	8.4
Rifampin	9	8.4	8.4
Polatuzumab Vedotin	6	8.3	8.3
Acyclovir	66	8.1	8.1
Dexamethasone 1.5 Mg	135	6.7	6.7
Acalabrutinib	6	6.7	6.7
Doxorubicin Hydrochloride	15	6.2	6.2
Miconazole Nitrate	4	6.2	6.2
Cisplatin	31	5.4	5.4
Fentanyl Citrate	7	5.3	5.3
Cetuximab	12	5.2	5.2
Temozolomide	8	5.1	5.1
Venetoclax	23	5.1	5.1
Pemetrexed	8	5.1	5.1
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	3	4.9	4.9
Sevelamer Carbonate	4	4.7	4.7
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	5	2.2	2.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.